Amylyx Pharmaceuticals (AMLX) Prepaid Assets (2021 - 2026)
Amylyx Pharmaceuticals (AMLX) posted quarterly Prepaid Assets of $5.3 million for Q1 2026, down 55.37% year-over-year from $11.8 million in Q1 2025, and down 21.46% quarter-over-quarter from $6.7 million in Q4 2025.
Amylyx Pharmaceuticals (AMLX) Prepaid Assets (2021 - 2026) Analysis & Trends
Amylyx Pharmaceuticals' Prepaid Assets history runs 6 years deep, the most recent figure standing at $5.3 million for Q1 2026.
- In Q1 2026, Prepaid Assets fell 55.37% year-over-year to $5.3 million; the TTM figure through Mar 2026 stood at $5.3 million (down 55.37% YoY), while the FY2025 annual figure was $6.7 million, down 46.4% from the prior year.
- Prepaid Assets for Q1 2026 stood at $5.3 million, down from $6.7 million in the prior quarter.
- The five-year high for Prepaid Assets was $17.3 million in Q3 2023, with the low at $5.3 million in Q1 2026.
- The 5-year median for Prepaid Assets is $10.3 million (2022), against an average of $10.9 million.
- The sharpest annual moves came in 2023 and 2026: Prepaid Assets surged 107.99% in 2023, then slumped 55.37% in 2026.
- Amylyx Pharmaceuticals' Prepaid Assets stood at $10.1 million in 2022, then surged by 47.64% to $14.9 million in 2023, then dropped by 16.39% to $12.5 million in 2024, then slumped by 46.4% to $6.7 million in 2025, then dropped by 21.46% to $5.3 million in 2026.
- Business Quant data shows AMLX's Prepaid Assets at $5.3 million in Q1 2026, $6.7 million in Q4 2025, and $9.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | Amylyx Pharmaceuticals | 4.35 Bn | 4.35 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.58 Mn |
| Mar 31, 2026 | 5.26 Mn |
| Dec 31, 2025 | 6.69 Mn |
| Sep 30, 2025 | 9.26 Mn |
| Jun 30, 2025 | 5.96 Mn |
| Mar 31, 2025 | 11.78 Mn |
| Dec 31, 2024 | 12.48 Mn |
| Sep 30, 2024 | 9.14 Mn |
| Jun 30, 2024 | 12.82 Mn |
| Mar 31, 2024 | 16.89 Mn |
| Dec 31, 2023 | 14.93 Mn |
| Sep 30, 2023 | 17.34 Mn |
| Jun 30, 2023 | 11.79 Mn |
| Mar 31, 2023 | 12.75 Mn |
| Dec 31, 2022 | 10.11 Mn |
| Sep 30, 2022 | 8.34 Mn |
| Jun 30, 2022 | 9.46 Mn |
| Mar 31, 2022 | 10.28 Mn |
| Dec 31, 2021 | 5.39 Mn |